Feasibility of assessing drug response to precise local injection of anti-cancer drugs using Presage’s CIVO™ device in soft tissue sarcoma patients undergoing surgery.
This study is investigating the microinjection of anti-cancer drugs followed by clinically-indicated surgical biopsy or tumor resection surgery.
Surgically resectable soft tissue sarcoma
18 years or older and surgically resectable soft tissue sarcoma
18 - 90
Healthy Volunteers Needed
Duration of Participation
A total of two in-person visits – one for tumor microinjection and one for tumor resection – are expected for this study. Total duration of participation expected to be 28 days.
Knight Clinical Trials Office